omiics is the company partner on multiple larger project applications
PRIME: omiics joined the ERC FET Open grant- EU PRIME, providing high-quality end-to-end RNAseq (Illumina technology), mainly focused on small RNA sequencing and analysis of novel tRNA fragment.
BIOMETSCO: omiics became the industry R&D partner in this ODIN project based at Aarhus Universtiy, developing novel data-analyse strategy of digital spatial profiling (DSP) data from the nCounter NanoString.
MICO Platform: omiics became the industry R&D partner in this ODIN project based at Aarhus Universtiy, establishing a single-cell (10X Genomics) analysis pipeline for organiod extracted neurons aimed at development of an in vitro model for biomarker testing and validation.
Innobooster: omiics was awarded a grant from the Innovation Foundation for the development of our interactive NGS software application.
CircRTrain consortium: omiics co-founder and CTO Morten Tillingsgaard Venø was a named partner in this Marie Curie Innovative Training Network (ITN) funded by the European Union within the H2020 Programme. (2017-2021)
RNA-NEURO: both omiicsco-founders, Yan Yan and Morten Tillingsgaard Venø, were named partners in this JPND (Joint Program in Neurodegeneration Research) cross-Disease Analysis Consortium. RNA-NEURO aimed to provide the fingerprint of small non-coding RNA in ALS, PD and FTD in both animal models and patient samples (serum/plasma) through RNA sequencing and modification analysis. (2017-2020)
EpiMiRNA: omiics co-founder and CTO Morten Tillingsgaard Venø was the named postdoc for this collaborative EU consortia project which investigated miRNA dysregulation in epilepsy. (2013-2018)
NGS service provider with a focus on customer needs. We deliver flexible solutions to your specific demands.
Contact us for a non-binding discussion about your next project.
(+45) 28 72 71 07
CVR: 39 73 23 43